Menu ×


Female Stress Urinary Incontinence Treatment Devices Market Analysis by Type (Urethral Sling, Artificial Urinary Sphincters, Electrical Stimulation Devices, and Catheters); by Product Type (Sling Systems, Pessaries, and Injectable Urethral Bulking Agents); and by End-User (Hospitals, Gynecological Clinics, and Home Care Settings) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • Renovia Inc. informed that Leva, a pelvic health system to treat women in urinary continence received acceptance from researchers supporting its value.
  • Boston Scientific Corporation declared that Solyx, a single incision sling system succeeded in the treatment of women with stress urinary incontinence.

Global Female Stress Urinary Incontinence Treatment Devices Market Highlights Over 2023 - 2033

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 667.1 Million

Forecast Year Market Size (2033)

~USD 1200.3 Million

The global female stress urinary incontinence treatment devices market is estimated to garner a revenue of ~USD 1200.3 million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 667.1 million in the year 2022. Rise in the number of female stress urinary incontinence treatment procedures. It is observed that in 2019, over 28o,000 procedures are performed per year.


Get more information on this reportDownload Sample PDF

Also, the rise of government initiatives to boost awareness regarding female stress urinary incontinence. U.S initiated a ‘Women’s Health Awareness (WHA)’ within the National Institute of Environmental Health Sciences to provide evidence-based community and increase community health resiliency.

Global Female Stress Urinary Incontinence Treatment Devices Market: Growth Drivers and Challenges

Growth Drivers

  • Increase in Instances of Urinary Incontinence – Stress incontinence is becoming more common in the geriatric population. The embarrassment caused by urinary continence is estimated to upsurge the market growth. The incidence of urinary incontinence in women ranged between 10%-65%.

  • Rising Prevalence of Gynecological Disorders – The prevalence of cases diagnosed with PCOS as per the estimations was 9% in 2021.

  • Growing Incidence of Urinary Incontinence Due to Menopause – Each year about 1 million women become menopausal in the U.S.

  • Rise of Occurrence of Tuberculosis – As of 2020, the number of tuberculosis cases per 100,000 population was 7,174.

  • Increase of Medical Conditions like Parkinson’s Disease, and Multiple Sclerosis – As the global estimates in 2019, over 8.5 million people have Parkinson’s disease doubled in 25 years.


  • Emergence of Neuromodulation for Electric Stimulation of Nerves

  • Limitation in Patients with the Fibrotic Urethra

  • Poor Procedural Outcomes

The global female stress urinary incontinence treatment devices market is segmented and analyzed for demand and supply by end-user into hospitals, gynecological clinics, and home care settings. Out of which, the hospitals segment is anticipated to hold the largest market size by the end of 2033 owing to the presence of developed healthcare infrastructure. The total number of all U.S hospitals was 6,093 in 2022.

Whereas, in type segment, the electrical stimulation devices sub-segment holds the largest market share of 54.42% as of 2022, owing to their ease of operation, and cost-effectiveness with the great convenience of being self- administered at home.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Female Stress Urinary Incontinence Treatment Devices Market Regional Synopsis

Regionally, the global female stress urinary incontinence treatment devices market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region holds the largest market share of 41% as of 2022. The market is estimated to grow on the back of a well-established healthcare infrastructure and high spending potential. The healthcare spending of the U.S in 2020 was USD 4000 billion.


The global female stress urinary incontinence treatment devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global female stress urinary incontinence treatment devices market includes the following segments:

By Type

  • Urethral Sling - 23.14%
  • Artificial Urinary Sphincters – 4.80%
  • Electrical Stimulation Devices – 54.42%
  • Catheters – 17.63%

By Product Type

  • Sling Systems
  • Pessaries
  • Injectable Urethral Bulking Agents

By End-User

  • Hospitals
  • Gynecological Clinics
  • Home Care Settings

Top Featured Companies Dominating the Global Female Stress Urinary Incontinence Treatment Devices Market

  • Boston Scientific Corporation

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Johnson & Johnson Services, Inc.
  • Becton, Dickinson and Company
  • Coloplast Corp.
  • CooperSurgical Inc.
  • MedGyn Products, Inc.
  • Cousin Biotech
  • Caldera Medical, Inc
  • Betatech Medical
  • FEG Textiltechnik MbH



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved